Thomas R D, Roy D
Department of Environmental Health Sciences, University of Alabama, Birmingham 35294, USA.
Carcinogenesis. 1995 Apr;16(4):891-5. doi: 10.1093/carcin/16.4.891.
We have demonstrated for the first time that mitoplasts (i.e. mitochondria without outer membrane) were able to convert stilbene estrogen (diethylstilbestrol, DES) to reactive metabolites, which covalently bind to mitochondrial (mt)DNA. Depending on the cofactor used, mitochondrial enzymes catalyzed the oxidation and/or reduction of DES. DES was oxidized to DES quinone by peroxide-supported mitochondrial enzyme. A Lineweaver-Burk plot of rate of formation of DES quinone at various substrate concentrations yielded a Km of 33 microM and Vmax of 39 nmol/mg protein/min. The oxidation of DES to DES quinone by mitochondria was drastically decreased by known inhibitors of cytochrome P450. DES quinone was reduced to DES by mitoplasts in the presence of NADH. The Km and Vmax for the DES quinone reduction in the absence of mitoplasts and NADH were 3.2 microM and 5.6 nmol respectively. The reduction of DES quinone to DES by mitoplasts was significantly inhibited by inhibitors of cytochrome b5 reductase and diaphorase. DES quinone was also reduced to DES by pure diaphorase, a mitochondrial reducing enzyme, in the presence of NADH. The Km and Vmax for the DES quinone reduction by diaphorase were 9.0 microM and 4.3 nmol respectively. Under reaction conditions similar to oxidation of DES to DES quinone by mitoplasts, it was observed that mitochondrial metabolic products of DES were able to covalently bind to mtDNA. These data provide direct evidence of mitochondrial enzyme-catalyzed oxidation and reduction reactions of DES. In the cell, activation of DES in the mitochondria (the organelle in which mtDNA synthesis, mtDNA repair and transcription systems are localized) is of utmost importance, because an analogous in vivo mitochondrial metabolism of DES through covalent modifications in mitochondrial genome may produce instability in the mitochondrial genome of the cells. These modifications may in turn play a role in the development of DES-induced hepatocarcinogenicity.
我们首次证明,线粒体(即没有外膜的线粒体)能够将芪类雌激素(己烯雌酚,DES)转化为反应性代谢产物,这些代谢产物会与线粒体(mt)DNA共价结合。根据所使用的辅助因子不同,线粒体酶催化DES的氧化和/或还原反应。在过氧化物支持的线粒体酶作用下,DES被氧化为DES醌。以不同底物浓度下DES醌形成速率绘制的Lineweaver-Burk图得出,Km为33微摩尔,Vmax为39纳摩尔/毫克蛋白质/分钟。细胞色素P450的已知抑制剂可显著降低线粒体将DES氧化为DES醌的反应。在NADH存在的情况下,线粒体将DES醌还原为DES。在没有线粒体和NADH时,DES醌还原反应的Km和Vmax分别为3.2微摩尔和5.6纳摩尔。细胞色素b5还原酶和黄递酶的抑制剂可显著抑制线粒体将DES醌还原为DES的反应。在NADH存在的情况下,纯黄递酶(一种线粒体还原酶)也可将DES醌还原为DES。黄递酶还原DES醌反应的Km和Vmax分别为9.0微摩尔和4.3纳摩尔。在与线粒体将DES氧化为DES醌相似的反应条件下,观察到DES的线粒体代谢产物能够与mtDNA共价结合。这些数据直接证明了线粒体酶催化的DES氧化和还原反应。在细胞中,DES在线粒体(mtDNA合成、mtDNA修复和转录系统所在的细胞器)中的激活至关重要,因为DES在线粒体基因组中通过共价修饰进行的类似体内线粒体代谢可能会导致细胞线粒体基因组的不稳定。这些修饰可能反过来在DES诱导的肝癌发生过程中发挥作用。